Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype.

PubWeight™: 2.38‹?› | Rank: Top 2%

🔗 View Article (PMC 3967096)

Published in Mol Psychiatry on July 01, 2008

Authors

N Craddock1, L Jones, I R Jones, G Kirov, E K Green, D Grozeva, V Moskvina, I Nikolov, M L Hamshere, D Vukcevic, S Caesar, K Gordon-Smith, C Fraser, E Russell, N Norton, G Breen, D St Clair, D A Collier, A H Young, I N Ferrier, A Farmer, P McGuffin, P A Holmans, Wellcome Trust Case Control Consortium (WTCCC), P Donnelly, M J Owen, M C O'Donovan

Author Affiliations

1: Department of Psychological Medicine, School of Medicine, Cardiff University, Cardiff, UK. craddockn@cardiff.ac.uk

Articles citing this

The Kraepelinian dichotomy - going, going... but still not gone. Br J Psychiatry (2010) 4.47

The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry (2009) 3.59

Dissecting the phenotype in genome-wide association studies of psychiatric illness. Br J Psychiatry (2009) 2.65

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov (2011) 2.65

Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses. Schizophr Bull (2009) 2.39

Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry (2010) 2.11

GABAA receptor trafficking-mediated plasticity of inhibitory synapses. Neuron (2011) 2.05

The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry (2010) 1.80

Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. Br J Psychiatry (2009) 1.45

gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biol Psychiatry (2010) 1.39

Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev (2009) 1.31

Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity. Biol Psychiatry (2011) 1.31

Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med (2014) 1.17

Polygenic dissection of the bipolar phenotype. Br J Psychiatry (2011) 1.17

Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study. Schizophr Res (2011) 1.10

GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders. Neuropharmacology (2009) 1.09

Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders. J Neurosci (2012) 1.05

Functional regulation of GABAA receptors in nervous system pathologies. Curr Opin Neurobiol (2011) 1.03

Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophr Bull (2014) 1.01

Rare variants in neuronal excitability genes influence risk for bipolar disorder. Proc Natl Acad Sci U S A (2015) 1.00

The genetic association between personality and major depression or bipolar disorder. A polygenic score analysis using genome-wide association data. Transl Psychiatry (2011) 0.99

mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway. Transl Psychiatry (2013) 0.98

Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl Psychiatry (2013) 0.98

White matter neuron alterations in schizophrenia and related disorders. Int J Dev Neurosci (2010) 0.94

Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism. Transl Psychiatry (2011) 0.93

GIT1 and βPIX are essential for GABA(A) receptor synaptic stability and inhibitory neurotransmission. Cell Rep (2014) 0.91

A twin study of schizoaffective-mania, schizoaffective-depression, and other psychotic syndromes. Am J Med Genet B Neuropsychiatr Genet (2011) 0.90

An examination of single nucleotide polymorphism selection prioritization strategies for tests of gene-gene interaction. Biol Psychiatry (2011) 0.89

Association of the GABRD gene and childhood-onset mood disorders. Genes Brain Behav (2010) 0.88

Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder. Semin Cell Dev Biol (2010) 0.87

Role of paliperidone extended-release in treatment of schizoaffective disorder. Neuropsychiatr Dis Treat (2010) 0.87

A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biol Psychiatry (2013) 0.87

Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder. Psychiatr Genet (2011) 0.85

Patterned expression of ion channel genes in mouse dorsal raphe nucleus determined with the Allen Mouse Brain Atlas. Brain Res (2012) 0.82

AprioriGWAS, a new pattern mining strategy for detecting genetic variants associated with disease through interaction effects. PLoS Comput Biol (2014) 0.80

Association study between GABA receptor genes and anxiety spectrum disorders. Depress Anxiety (2009) 0.80

Innovative approaches to bipolar disorder and its treatment. Ann N Y Acad Sci (2016) 0.80

Neurodevelopmental disorders among individuals with duplication of 4p13 to 4p12 containing a GABAA receptor subunit gene cluster. Eur J Hum Genet (2013) 0.78

A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia. Ment Illn (2010) 0.78

The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. Schizophr Res (2010) 0.76

Messages from hypothesis-driven genotyping: the case of schizoaffective disorder, bipolar type. Mol Psychiatry (2010) 0.75

An Efficient Stepwise Statistical Test to Identify Multiple Linked Human Genetic Variants Associated with Specific Phenotypic Traits. PLoS One (2015) 0.75

Early developmental bisphenol-A exposure sex-independently impairs spatial memory by remodeling hippocampal dendritic architecture and synaptic transmission in rats. Sci Rep (2016) 0.75

Triangulating perspectives on functional neuroimaging for disorders of mental health. BMC Psychiatry (2013) 0.75

Cortical Alpha Activity in Schizoaffective Patients. Iran J Psychiatry (2017) 0.75

Articles cited by this

PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95

Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23

Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry (1978) 15.32

Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res (2001) 9.41

SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry (1990) 8.52

A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry (1991) 6.74

The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry (2003) 5.15

The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry (2005) 4.51

The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet (2005) 4.02

Bipolar disorder. Lancet (2002) 3.26

The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry (2007) 3.15

GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci (2001) 3.09

Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry (2007) 2.82

Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry (2005) 2.58

Constructing inhibitory synapses. Nat Rev Neurosci (2001) 2.43

Genetics of bipolar disorder. J Med Genet (1999) 2.35

GABA(A) receptor diversity and pharmacology. Cell Tissue Res (2006) 2.19

Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry (2006) 2.16

GABAergic dysfunction in mood disorders. Mol Psychiatry (2003) 2.01

Role of GABA in anxiety and depression. Depress Anxiety (2007) 1.79

Analysis of the set of GABA(A) receptor genes in the human genome. J Biol Chem (2004) 1.70

Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry (2006) 1.66

The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem Pharmacol (2004) 1.57

Carving chaos: genetics and the classification of mood and psychotic syndromes. Harv Rev Psychiatry (2006) 1.49

Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry (2005) 1.48

Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry (2004) 1.46

The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol Psychiatry (2006) 1.44

The Bipolar Affective Disorder Dimension Scale (BADDS)--a dimensional scale for rating lifetime psychopathology in bipolar spectrum disorders. BMC Psychiatry (2004) 1.38

Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. Am J Psychiatry (2003) 1.36

Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families. Mol Psychiatry (2005) 1.27

Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes? Eur Arch Psychiatry Clin Neurosci (2005) 1.13

Molecular genetics of bipolar disorder. Genes Brain Behav (2006) 1.08

Bipolar disorder and schizophrenia: not so distant relatives? World Psychiatry (2003) 0.98

Genetic tests of biologic systems in affective disorders. Mol Psychiatry (2005) 0.92

Genome-wide association in bipolar. Mol Psychiatry (2008) 0.85

Articles by these authors

Inference of population structure using multilocus genotype data. Genetics (2000) 147.76

A new statistical method for haplotype reconstruction from population data. Am J Hum Genet (2001) 59.30

The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47

Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (2007) 32.97

Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess (2004) 29.45

Changing provider behavior: an overview of systematic reviews of interventions. Med Care (2001) 17.89

Association mapping in structured populations. Am J Hum Genet (2000) 16.79

The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell (1997) 13.53

The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry (1988) 12.83

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Inferring coalescence times from DNA sequence data. Genetics (1997) 8.08

Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47

Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet (2004) 7.33

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet (2000) 6.78

A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry (1991) 6.74

Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet (2011) 6.36

The Genome Sequence DataBase: towards an integrated functional genomics resource. Nucleic Acids Res (1999) 6.20

Estimating recombination rates from population genetic data. Genetics (2001) 5.95

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry (1999) 5.54

Case-control studies of association in structured or admixed populations. Theor Popul Biol (2001) 5.46

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91

Regional variations in the use of common surgical procedures: within and between England and Wales, Canada and the United States of America. Soc Sci Med A (1981) 4.88

Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med (1991) 4.68

The compromised host and infection. II. Deep fungal infection. J Infect Dis (1969) 4.63

The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia? Br J Psychiatry (1994) 4.40

Partition structures, Polya urns, the Ewens sampling formula, and the ages of alleles. Theor Popul Biol (1986) 4.35

Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell (1994) 4.07

Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature (1984) 4.04

Screening could seriously damage your health. BMJ (1997) 4.04

The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet (2005) 4.02

Use of computerised general practice data for population surveillance: comparative study of influenza data. BMJ (1991) 3.99

Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85

The chemistry and biology of unusual DNA structures adopted by oligopurine.oligopyrimidine sequences. FASEB J (1988) 3.84

Health checks in general practice: another example of inverse care? BMJ (1990) 3.83

Jefferson fathered slave's last child. Nature (1998) 3.83

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry (2002) 3.78

Lithium neurotoxicity at normal therapeutic levels. Br J Psychiatry (1993) 3.76

Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci U S A (1999) 3.75

The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry (2009) 3.59

Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry (2004) 3.54

LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry (2007) 3.49

A total audit of preventive procedures in 45 practices caring for 430,000 patients. BMJ (1990) 3.45

Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev (2001) 3.43

Methods for estimating the case fatality ratio for a novel, emerging infectious disease. Am J Epidemiol (2005) 3.40

ISYS: a decentralized, component-based approach to the integration of heterogeneous bioinformatics resources. Bioinformatics (2001) 3.36

The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry (2007) 3.34

The bipolar-borderline personality disorders connection in major depressive patients. Acta Psychiatr Scand (2013) 3.12

Heterogeneity of microsatellite mutations within and between loci, and implications for human demographic histories. Genetics (1998) 3.12

Lack of willpower or lack of wherewithal? "Internal" and "external" barriers to changing diet and exercise in a three year follow-up of participants in a health check. Soc Sci Med (1998) 3.10

Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10

Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry (1999) 3.07

Community-based prevalence of anal incontinence. JAMA (1995) 3.03

Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry (2008) 3.01

New evidence on the state of stress of the san andreas fault system. Science (1987) 2.97

Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry (2010) 2.95

Biosynthesis of HLA-A and HLA-B antigens in vivo. J Biol Chem (1980) 2.94

Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. Science (1992) 2.90

How convincing is DNA evidence? Nature (1994) 2.90

On-line computer quality control of antibiotic-sensitivity testing. N Engl J Med (1970) 2.88

SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet (2001) 2.86

Needs assessment in primary care: general practitioners' perceptions and implications for the future. Br J Gen Pract (2000) 2.86

Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet (1997) 2.83

The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry (2010) 2.82

Medical complications after stroke: a multicenter study. Stroke (2000) 2.81

The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80

Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (1990) 2.80

Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry (2005) 2.78

Molecular cloning of the human T-lymphocyte surface CD2 (T11) antigen. Proc Natl Acad Sci U S A (1986) 2.76

T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol (1997) 2.76

The distribution and causes of meiotic recombination in the human genome. Biochem Soc Trans (2006) 2.73

Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry (2002) 2.69